By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Tesaro, Inc. (Waltham, Massachusetts) 

309 Waverley Oaks Road
Suite #101
Waltham  Massachusetts  02452  U.S.A.
Phone: 339-970-0900 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Tesaro (TSRO) Release: National Survey Shows Resource, Emotional And Support Needs Of The Ovarian Cancer Community 5/22/2017 10:26:43 AM
McKesson Specialty Health Selected By Tesaro (TSRO) To Provide ZEJULA (Niraparib), Approved For The Treatment Of Recurrent Ovarian Cancer 5/12/2017 12:50:11 PM
Tesaro (TSRO) Partners With Clinigen To Initiate European Managed Access Program For Niraparib In Patients With Recurrent Ovarian Cancer 5/11/2017 11:57:18 AM
Tesaro (TSRO) Announces First-Quarter 2017 Operating Results 5/10/2017 11:07:52 AM
Tesaro (TSRO) Announces Submission Of Investigational New Drug Application For Anti-LAG Antibody TSR-033 To The FDA 5/1/2017 10:15:56 AM
Tesaro (TSRO) Initiates Registrational Development Program For Anti-PD-1 Antibody TSR-042 4/27/2017 9:40:59 AM
Tesaro (TSRO) To Announce First-Quarter 2017 Financial Results On May 9, 2017 4/26/2017 12:52:01 PM
Tesaro (TSRO) Announces Participation In Two Investor Conferences 4/26/2017 12:47:51 PM
Tesaro (TSRO) To Announce First-Quarter 2017 Financial Results On May 9, 2017 4/26/2017 11:00:02 AM
Tesaro (TSRO) Announces Approval Of VARUBY (Oral Rolapitant Tablets) By European Commission (EC) 4/26/2017 10:27:58 AM
12345678910...
//-->